Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,354 | 342 | 97.5% |
| Education | $123.10 | 5 | 2.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $14.64 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $568.71 | 38 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $549.56 | 39 | $0 (2021) |
| Astellas Pharma US Inc | $495.82 | 22 | $0 (2024) |
| Allergan, Inc. | $454.48 | 39 | $0 (2020) |
| ABBVIE INC. | $429.36 | 23 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $322.82 | 21 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $229.80 | 13 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $221.15 | 14 | $0 (2019) |
| Novo Nordisk Inc | $185.69 | 12 | $0 (2020) |
| Takeda Pharmaceuticals U.S.A., Inc. | $168.75 | 11 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $297.69 | 13 | AstraZeneca Pharmaceuticals LP ($58.20) |
| 2023 | $192.00 | 11 | PFIZER INC. ($98.09) |
| 2022 | $418.14 | 21 | ABBVIE INC. ($171.38) |
| 2021 | $455.89 | 24 | AbbVie Inc. ($220.67) |
| 2020 | $424.15 | 27 | PFIZER INC. ($165.09) |
| 2019 | $1,141 | 79 | PFIZER INC. ($123.30) |
| 2018 | $1,245 | 88 | Janssen Pharmaceuticals, Inc ($198.16) |
| 2017 | $1,318 | 85 | Allergan Inc. ($180.21) |
All Payment Transactions
348 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/22/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $28.76 | General |
| Category: Biological | ||||||
| 10/15/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $43.69 | General |
| Category: NEUROSCIENCE | ||||||
| 10/11/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $25.33 | General |
| Category: Biological | ||||||
| 07/30/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: Respiratory | ||||||
| 06/06/2024 | Baxter Healthcare | Hillrom - Carnation Ambulatory Monitor (Device) | Food and Beverage | In-kind items and services | $23.38 | General |
| Category: Cardiac Arrhythmia Monitoring | ||||||
| 06/01/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $24.99 | General |
| Category: UROLOGY | ||||||
| 05/21/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $22.11 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/03/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $18.17 | General |
| Category: PSYCHIATRY | ||||||
| 03/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.94 | General |
| Category: DIABETES | ||||||
| 03/05/2024 | PFIZER INC. | PREVNAR 20 (Biological), ABRYSVO | Food and Beverage | In-kind items and services | $20.70 | General |
| Category: VACCINES | ||||||
| 02/20/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/26/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.89 | General |
| Category: RESPIRATORY | ||||||
| 01/09/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.64 | General |
| Category: DIABETES | ||||||
| 10/31/2023 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.91 | General |
| Category: PAIN | ||||||
| 09/22/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/11/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.25 | General |
| Category: RESPIRATORY | ||||||
| 07/18/2023 | PFIZER INC. | PREVNAR 20 (Biological), ABRYSVO | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: VACCINES | ||||||
| 06/16/2023 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $23.44 | General |
| Category: Urology | ||||||
| 06/13/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: DIABETES | ||||||
| 05/19/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $17.89 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 04/18/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.13 | General |
| Category: NEUROSCIENCE | ||||||
| 03/07/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.18 | General |
| Category: NEUROSCIENCE | ||||||
| 02/24/2023 | PFIZER INC. | PREVNAR 20 (Biological) | Food and Beverage | In-kind items and services | $14.69 | General |
| Category: VACCINES | ||||||
| 01/10/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/14/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $26.27 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 1,065 | 1,568 | $250,993 | $103,208 |
| 2022 | 17 | 1,030 | 1,163 | $213,601 | $93,243 |
| 2021 | 16 | 1,095 | 1,257 | $219,113 | $95,938 |
| 2020 | 17 | 1,057 | 1,273 | $225,268 | $88,168 |
All Medicare Procedures & Services
69 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 168 | 209 | $47,025 | $18,448 | 39.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 130 | 130 | $29,250 | $17,657 | 60.4% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 72 | 338 | $33,800 | $17,328 | 51.3% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 70 | 79 | $29,625 | $11,937 | 40.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 91 | 126 | $20,790 | $8,209 | 39.5% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 58 | 181 | $36,200 | $7,038 | 19.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 31 | 31 | $9,610 | $4,146 | 43.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 47 | 47 | $5,405 | $3,381 | 62.5% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 11 | 11 | $4,400 | $3,102 | 70.5% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 131 | 131 | $6,550 | $2,579 | 39.4% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 29 | 31 | $5,487 | $2,300 | 41.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 54 | 54 | $2,700 | $1,755 | 65.0% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 27 | 32 | $4,800 | $1,410 | 29.4% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 21 | 21 | $3,255 | $1,145 | 35.2% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 11 | 23 | $3,450 | $772.42 | 22.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 68 | 68 | $5,100 | $717.24 | 14.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 12 | 13 | $1,300 | $620.57 | 47.7% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 11 | 11 | $550.00 | $357.50 | 65.0% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 23 | 32 | $1,696 | $304.64 | 18.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 201 | 264 | $59,400 | $24,421 | 41.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 139 | 139 | $31,275 | $19,392 | 62.0% |
| 99306 | Initial nursing facility visit per day, typically 45 minutes | Facility | 2022 | 111 | 121 | $45,375 | $16,602 | 36.6% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 26 | 26 | $11,025 | $7,177 | 65.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 84 | 107 | $17,655 | $6,805 | 38.5% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 43 | 43 | $3,870 | $3,021 | 78.1% |
About Dr. Wayne Paulekas, MD
Dr. Wayne Paulekas, MD is a Internal Medicine healthcare provider based in Wethersfield, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/23/2005. The National Provider Identifier (NPI) number assigned to this provider is 1730166422.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Wayne Paulekas, MD has received a total of $5,491 in payments from pharmaceutical and medical device companies, with $297.69 received in 2024. These payments were reported across 348 transactions from 48 companies. The most common payment nature is "Food and Beverage" ($5,354).
As a Medicare-enrolled provider, Paulekas has provided services to 4,247 Medicare beneficiaries, totaling 5,261 services with total Medicare billing of $380,557. Data is available for 4 years (2020–2023), covering 69 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Wethersfield, CT
- Active Since 12/23/2005
- Last Updated 03/07/2023
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1730166422
Products in Payments
- VRAYLAR (Drug) $419.50
- XARELTO (Drug) $344.00
- FARXIGA (Drug) $273.95
- UBRELVY (Drug) $223.80
- JARDIANCE (Drug) $218.64
- INVOKANA (Drug) $199.54
- CHANTIX (Drug) $195.70
- Trintellix (Drug) $149.45
- SOLIQUA (Drug) $141.97
- Myrbetriq (Drug) $130.62
- MYRBETRIQ (Drug) $124.79
- JANUVIA (Drug) $101.75
- TRELEGY ELLIPTA (Drug) $100.09
- NUEDEXTA (Drug) $93.77
- TRULICITY (Drug) $92.94
- XIFAXAN (Drug) $92.62
- LYRICA (Drug) $90.67
- ENTRESTO (Drug) $90.50
- REXULTI (Drug) $89.40
- ELIQUIS (Drug) $88.99
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Wethersfield
Komsu Mamuya, Md, MD
Internal Medicine — Payments: $43,005
Frederick Pope, Md, MD
Internal Medicine — Payments: $9,433
Dr. Scott Walker, M.d, M.D
Internal Medicine — Payments: $9,291
Anne Pinou, Md, MD
Internal Medicine — Payments: $4,291
Robert Reginio, Md, MD
Internal Medicine — Payments: $996.29
Dr. Thomas Brown, M.d, M.D
Internal Medicine — Payments: $506.56